Science ❯Biotechnology ❯Drug Development

Clinical Trials

Lung Cancer RSV and Cancer Vaccines GLP-1 Receptor Agonists BNT327

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

Moderna to Cut $1.1 Billion in R&D Spending as Vaccine Sales Decline

Summit Therapeutics' Lung Cancer Drug Outperforms Merck's Keytruda in Trial